Ranbaxy ‘Sold Adulterated Drugs Liptor’, Admits
Ranbaxy, the international Drug Manufacturer admitted in the United States to charges of making and distributing adulterated drugs at its two Indian plants of Paonta Sahib and Dewas and agreed to a $500 million settlement. “Daiichi Sankyo believes certain former shareholders of Ranbaxy…
You must be logged in to post a comment.